<DOC>
	<DOCNO>NCT00357370</DOCNO>
	<brief_summary>The purpose clinical research study learn BMS-512148 , add insulin one two anti-diabetes medication ( metformin and/or pioglitazone rosiglitazone ) , help reduce blood sugar level compare insulin one two anti-diabetes medication ( metformin and/or pioglitazone rosiglitazone ) alone , subject type 2 diabetes . The safety treatment also study .</brief_summary>
	<brief_title>A Pilot Study BMS-512148 Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Males female , 18 75 year old , type 2 diabetes inadequate glycemic control Subjects receive insulin metformin and/or thiazolidinedione Body Mass Index &lt; =45.0 kg/m2 Serum creatinine &lt; 1.5 mg/dL men &lt; 1.4 mg/dL woman No overt proteinuria ( subject microalbumin/creatinine ratio ≥300 mg/g , 24hour urinary excretion total protein must &lt; 3 g/24 hr ) History type 1 diabetes AST and/or ALT &gt; 2.5 time upper limit normal Creatinine kinase ≥3 time upper limit normal Symptoms severely uncontrolled diabetes History hypoglycemic unawareness Currently unstable serious cardiovascular , renal , hepatic , hematological , oncological , endocrine , psychiatric , rheumatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>